Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.

Support the Forward

Funded by readers like you DonateSubscribe
Fast Forward

Rabbi who recovered from COVID donates plasma in experimental treatment

(JTA) — Among the mysteries of the coronavirus is that some patients suffer and ultimately die from the disease while others experience the symptoms as akin to a mild cold.

Rabbi Daniel Nevins is in the latter category. The dean of the rabbinical school at the Jewish Theological Seminary, Nevins was laid up for a few days earlier this month with a fever and some aches, and then recovered.

Nevins was tested for the coronavirus on March 12 and a week later got back a positive result. A week after that, he was tested again. Friday morning, he got the result: All clear.

Within hours, Nevins was hooked up to a machine at Mount Sinai Hospital in New York to donate blood plasma. In the race to develop effective treatments for the disease, researchers are investigating whether antibodies from the blood of people who have successfully fought off the disease may provide treatment for people who with more serious symptoms.

As a public service during this pandemic, the Forward is providing free, unlimited access to all coronavirus articles. If you’d like to support our independent Jewish journalism, click here.

Earlier this week, the Food and Drug Administration allowed doctors to treat critically ill coronavirus patients with plasma on an experimental basis. Plasma has been shown effective in treating other infectious diseases, like polio, measles and influenza.

“I felt fortunate that my mild case of this illness might turn into a blessing for people who are seriously ill,” Nevins told the Jewish Telegraphic Agency. “The Torah teaches us not to stand idly by the blood of our neighbor. My Midrash [interpretation] is that no, instead lie down in a donor bed and give plasma.”

Mount Sinai was among the first hospitals in the country to figure out how to detect antibodies in the blood of people who had recovered from coronavirus, the New York Times reported. Whether or not those antibodies are effective remains to be seen.

“It’s kind of difficult scientifically to know how valuable it is in any disease until you try,” said David Reich, the president and chief operating officer of Mount Sinai, told the Times. “It’s not exactly a shot in the dark, but it’s not tried and true.”

The post Rabbinical school dean participates in experimental coronavirus treatment appeared first on Jewish Telegraphic Agency.

Engage

  • SHARE YOUR FEEDBACK

  • UPCOMING EVENT

    SKY & SCULPTURE

    Hybrid: Online and at the Marlene Meyerson JCC Manhattan

    Oct 2, 2022

    6:30 pm ET · 

    A Sukkah, IMKHA, created by artist Tobi Kahn, for the Marlene Meyerson JCC of Manhattan is an installation consisting of 13 interrelated sculpted painted wooden panels, constituting a single work of art. Join for a panel discussion with Rabbi Joanna Samuels, Chief Executive Director of the Marlene Meyerson JCC of Manhattan, Talya Zax, Innovation Editor of the Forward, and Tobi Kahn, Artist. Moderated by Mattie Kahn.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.